Effect of Bifidobacterium Breve B-3 on Body Fat in Obese Adults
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03774381|
Recruitment Status : Recruiting
First Posted : December 13, 2018
Last Update Posted : December 13, 2018
|Condition or disease||Intervention/treatment||Phase|
|Obesity||Dietary Supplement: Bifidobacterium breve B-3 Dietary Supplement: Control group||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Effect of Bifidobacterium Breve B-3 on Body Fat in Obese Adults|
|Actual Study Start Date :||September 1, 2018|
|Estimated Primary Completion Date :||May 30, 2019|
|Estimated Study Completion Date :||July 31, 2019|
Experimental: Bifidobacterium breve B-3 group
160 mg mg of Bifidobacterium breve B-3 was orally administered per day for 12 weeks.
Dietary Supplement: Bifidobacterium breve B-3
160 mg of Bifidobacterium breve B-3 is orally administered per day for 12 weeks.
Placebo Comparator: Control group
160 mg of placebo was orally administered per day for 12 weeks.
Dietary Supplement: Control group
160 mg of placebo is orally administered per day for 12 weeks.
- Body fat [ Time Frame: Change from baseline body fat at 12 weeks ]dual energy x-ray absorptiometry (DEXA)
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03774381
|Contact: Sang Yeoup Lee, MD||3602860 ext email@example.com|
|Korea, Republic of|
|Integrated Research Institute for Natural Ingredients and Functional Foods||Recruiting|
|Yangsan, Korea, Republic of, 50612|
|Contact: Sang Yeoup Lee, MD 82-55-360-2860 firstname.lastname@example.org|
|Principal Investigator:||Sang Yeoup Lee, MD||Pusan National University Yangsan Hospital|